Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals

被引:5
作者
Singh, Manisha [1 ]
Singh, Surinder P. [2 ]
Yadav, Deepshikha [2 ,3 ,4 ]
Agarwal, Mugdha [1 ]
Agarwal, Shriya [1 ]
Agarwal, Vinayak [1 ]
Swargiary, Geeta [1 ]
Srivastava, Sahil [1 ]
Tyagi, Sakshi [1 ]
Kaur, Ramneek [5 ]
Mani, Shalini [1 ]
机构
[1] Jaypee Inst Informat Technol JILT Noida, Dept Biotechnol, Noida, UP, India
[2] CSIR Natl Phys Lab, Bhartiya Nirdeshak Dravya Div, New Delhi, India
[3] CSIR Natl Phys Lab, Physicomech Metrol Div, New Delhi, India
[4] Acad Sci & Innovat Res AcSIR, Ghaziabad, UP, India
[5] Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia
关键词
Gene therapy; neurodegenerative diseases; viral vectors; nonviral vectors; Alzheimer disease; Parkinson disease; schizophrenia retroviruses; SPINAL-MUSCULAR-ATROPHY; SURVIVAL-MOTOR-NEURON; AMYOTROPHIC-LATERAL-SCLEROSIS; MOUSE MODEL; PARKINSONS-DISEASE; IN-VIVO; ALZHEIMERS-DISEASE; PROLONGS SURVIVAL; MULTIPLE-SCLEROSIS; MUTANT HUNTINGTIN;
D O I
10.2174/1566523220999200817164907
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The technique of gene therapy, ever since its advent nearly fifty years ago, has been utilized by scientists as a potential treatment option for various disorders. This review discusses some of the major neurodegenerative diseases (NDDs) like Alzheimer's disease (AD), Parkinson's Disease (PD), Motor neuron diseases (MND), Spinal Muscular Atrophy (SMA), Huntington's Disease (HD), Multiple Sclerosis (MS), etc. and their underlying genetic mechanisms along with the role that gene therapy can play in combating them. The pathogenesis and the molecular mechanisms specifying the altered gene expression of each of these NDDs have also been discussed in elaboration. The use of gene therapy vectors can prove to be an effective tool in the field of curative modern medicine for the generations to come. Therefore, consistent efforts and progressive research towards its implementation can provide us with powerful treatment options for disease conditions that have so far been considered as incurable.
引用
收藏
页码:23 / 42
页数:20
相关论文
共 166 条
  • [1] Agbandje-McKenna M, 2011, METHODS MOL BIOL, V807, P47, DOI 10.1007/978-1-61779-370-7_3
  • [2] RNA interference: Biology, mechanism, and applications
    Agrawal, N
    Dasaradhi, PVN
    Mohmmed, A
    Malhotra, P
    Bhatnagar, RK
    Mukherjee, SK
    [J]. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2003, 67 (04) : 657 - +
  • [3] Molecular Mechanisms of Neurodegeneration in Spinal Muscular Atrophy
    Ahmad, Saif
    Bhatia, Kanchan
    Kannan, Annapoorna
    Gangwani, Laxman
    [J]. JOURNAL OF EXPERIMENTAL NEUROSCIENCE, 2016, 10 : 39 - 49
  • [4] Gene transfer into the mouse retina mediated by an adeno-associated viral vector
    Ali, RR
    Reichel, MB
    Thrasher, AJ
    Levinsky, RJ
    Kinnon, C
    Kanuga, N
    Hunt, DM
    Bhattacharya, SS
    [J]. HUMAN MOLECULAR GENETICS, 1996, 5 (05) : 591 - 594
  • [5] Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice
    Alves, Sandro
    Churlaud, Guillaume
    Audrain, Mickael
    Michaelsen-Preusse, Kristin
    Fol, Romain
    Souchet, Benoit
    Braudeau, Jerome
    Korte, Martin
    Klatzmann, David
    Cartier, Nathalie
    [J]. BRAIN, 2017, 140 : 826 - 842
  • [6] The Sleeping Beauty transposon system: a non-viral vector for gene therapy
    Aronovich, Elena L.
    McIvor, R. Scott
    Hackett, Perry B.
    [J]. HUMAN MOLECULAR GENETICS, 2011, 20 : R14 - R20
  • [7] Spinal Muscular Atrophy: Journeying From Bench to Bedside
    Awano, Tomoyuki
    Kim, Jeong-Ki
    Monani, Umrao R.
    [J]. NEUROTHERAPEUTICS, 2014, 11 (04) : 786 - 795
  • [8] VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model
    Azzouz, M
    Ralph, GS
    Storkebaum, E
    Walmsley, LE
    Mitrophanous, KA
    Kingsman, SM
    Carmeliet, P
    Mazarakis, ND
    [J]. NATURE, 2004, 429 (6990) : 413 - 417
  • [9] Gene Therapy for Parkinson's Disease: Preclinical Evaluation of Optimally Configured TH:CH1 Fusion for Maximal Dopamine Synthesis
    Badin, Romina Aron
    Binley, Katie
    Van Camp, Nadja
    Jan, Caroline
    Gourlay, Jeanne
    Robert, Camille
    Gipchtein, Pauline
    Fayard, Audrey
    Stewart, Hannah
    Ralph, G. Scott
    Lad, Yatish
    Kelleher, Michelle
    Loader, Julie
    Hosomi, Koichi
    Palfi, Stephane
    Mitrophanous, Kyriacos A.
    Hantraye, Philippe
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 14 : 206 - 216
  • [10] Development of Intrathecal AAV9 Gene Therapy for Giant Axonal Neuropathy
    Bailey, Rachel M.
    Armao, Diane
    Kalburgi, Sahana Nagabhushan
    Gray, Steven J.
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2018, 9 : 160 - 171